Chemical Compound
((3~(R),5~(S),6~(S),7~(R),8~(S),9~(R),12~(R),13~(S),14~(R),15~(R))-6-((2~(S),3~(R),4~(S),6~(R))-3-acetyloxy-4-(dimethylamino)-6-methyloxan-2-yl)oxy-8-((2~(R),4~(S),5~(S),6~(S))-5-acetyloxy-4-methoxy-6-methyloxan-2-yl)oxy-5,7,9,12,13,15-hexamethyl-10,16-dioxo-1,11-dioxaspiro(2.13)hexadecan-14-yl) acetate
CAS Registry Number
2751-09-9
Primary record
((3~(R),5~(S),6~(S),7~(R),8~(S),9~(R),12~(R),13~(S),14~(R),15~(R))-6-((2~(S),3~(R),4~(S),6~(R))-3-acetyloxy-4-(dimethylamino)-6-methyloxan-2-yl)oxy-8-((2~(R),4~(S),5~(S),6~(S))-5-acetyloxy-4-methoxy-6-methyloxan-2-yl)oxy-5,7,9,12,13,15-hexamethyl-10,16-dioxo-1,11-dioxaspiro(2.13)hexadecan-14-yl) acetate
- 库存
- 8,569 克
- 纯度
- 98.1 %
- CAS
- 2751-09-9
化合物标识与属性
- CAS
- 2751-09-9
- PubChem CID
- 202225
- SMILES
- C[C@@H]1C[C@@H]([C@H]([C@@H](O1)O[C@H]2[C@H](C[C@@]3(CO3)C(=O)[C@@H]([C@H]([C@H]([C@H](OC(=O)[C@@H]([C@H]([C@@H]2C)O[C@H]4C[C@@H]([C@H]([C@@H](O4)C)OC(=O)C)OC)C)C)C)OC(=O)C)C)C)OC(=O)C)N(C)C
- Canonical SMILES
- CO[C@H]1C[C@H](O[C@H]2[C@H](C)[C@@H](O[C@@H]3O[C@H](C)C[C@H](N(C)C)[C@H]3OC(C)=O)[C@@H](C)C[C@@]3(CO3)C(=O)[C@H](C)[C@@H](OC(C)=O)[C@@H](C)[C@@H](C)OC(=O)[C@@H]2C)O[C@@H](C)[C@@H]1OC(C)=O
名称与同义词
- TROLEANDOMYCIN
- Triacetyloleandomycin
- Oleandocetine
- Tribiocillina
- Oleandomycin triacetate
- Troleandomicina
- Troleandomycine
- Cyclamycin
- Evramicina
- Triocetin
- Troleandomycinum
- Matromicina
- Treolmicina
- evramycin
- oleomycin
- Oleandocetin
- Tekmisin
- Viamicina
- Micotil
- Triolan
- Wytrion
- Aovine
- Oleandomycin triacetyl ester
- Matromycin T
- Treis-Micina
- Triacetyloleandomycinum
- oleandomycin triacetate ester
- Oleandomycin, triacetate (ester)
- ACETYLOLEANDOMYCIN
- Tao (VAN)
- oleandomycintriacetylester
- RefChem:56183
- Oleandomycin, triacetyl-
- Tao (TN)
- 2751-09-9
- Prestwick3_000036
- GlyTouCan:G04044FQ
- DTXSID2023721
- Oleandomycin (as troleandomycin)
- TROLEANDOMYCIN [MI]
- Triacetyloleandomycin (JAN)
- C4DZ64560D
- Troleandomycin (USAN/INN)
- TROLEANDOMYCIN [INN]
- BSPBio_000131
- TROLEANDOMYCIN [USAN]
- CHEBI:45735
- Troleandomycine [INN-French]
- Troleandomycinum [INN-Latin]
- SCHEMBL125071
- TROLEANDOMYCIN [VANDF]
- UNII-C4DZ64560D
- Troleandomicina [INN-Spanish]
- LQCLVBQBTUVCEQ-QTFUVMRISA-N
- Triacetyl ester of oleandomycin
- TROLEANDOMYCIN [MART.]
- AC1L483V
- BPBio1_000145
- CHEMBL564085
- MSK7804B
- orb1705216
- T.A.O.
- TROLEANDOMYCIN [WHO-DD]
- NSC-108166
- ERK5-2D16
- J01FA08
- C41H67NO15
- DTXCID501765951
- HMS2089B10
- HMS2095G13
- HMS3712G13
- TRIACETYLOLEANDOMYCIN [JAN]
- Fmoc-(R)-3-Amino-5-hexenoicacid
- MSK7804B-100A
- EX-A8207
- G04044FQ
- EINECS 220-392-9
- MSK7804B-1000A
- TROLEANDOMYCIN [ORANGE BOOK]
- BDBM50370258
- CID202225
- LMPK04000042
- MFCD00871198
- NSC108166
- TROLEANDOMYCIN [USP IMPURITY]
- WY 651
- Troleandomycin [USAN:USP:INN:BAN]
- ZINC169307271
- CCG-220036
- CID:202225
- DB13179
- NSC 108166
- NCGC00179654-01
- SID:53789840
- AI3-50166
- HY-108881
- AB00513798
- CS-0031241
- NS00001230
- C12753
- D01322
- G12808
- AB00513798-02
- OLEANDOMYCIN (AS TROLEANDOMYCIN) [VANDF]
- TAO
- A942019
- D014217
- Troleandomycin Solution in Acetonitrile, 100ug/mL
- Q1087499
- Troleandomycin Solution in Acetonitrile, 1000ug/mL
- BRD-K38310698-001-01-9
- [(3R,5S,6S,7R,8S,9R,12R,13S,14S,15R)-6-[(2S,3R,4S,6R)-3-acetyloxy-4-(dimethylamino)-6-methyloxan-2-yl]oxy-8-[(2R,4S,5S,6S)-5-acetyloxy-4-methoxy-6-methyloxan-2-yl]oxy-5,7,9,12,13,15-hexamethyl-10,16-dioxo-1,11-dioxaspiro[2.13]hexadecan-14-yl] acetate
- ((3~(R),5~(S),6~(S),7~(R),8~(S),9~(R),12~(R),13~(S),14~(R),15~(R))-6-((2~(S),3~(R),4~(S),6~(R))-3-acetyloxy-4-(dimethylamino)-6-methyloxan-2-yl)oxy-8-((2~(R),4~(S),5~(S),6~(S))-5-acetyloxy-4-methoxy-6-methyloxan-2-yl)oxy-5,7,9,12,13,15-hexamethyl-10,16-dioxo-1,11-dioxaspiro(2.13)hexadecan-14-yl) acetate
- ((3R,5S,6S,7R,8S,9R,12R,13S,14S,15R)-6-((2S,3R,4S,6R)-3-acetyloxy-4-(dimethylamino)-6-methyloxan-2-yl)oxy-8-((2R,4S,5S,6S)-5-acetyloxy-4-methoxy-6-methyloxan-2-yl)oxy-5,7,9,12,13,15-hexamethyl-10,16-dioxo-1,11-dioxaspiro(2.13)hexadecan-14-yl) acetate
- ((3S,5S,6S,7R,8S,9R,12R,13S,14S,15R)-6-((2S,3R,4S,6R)-3-acetyloxy-4-(dimethylamino)-6-methyloxan-2-yl)oxy-8-((2R,4S,5S,6S)-5-acetyloxy-4-methoxy-6-methyloxan-2-yl)oxy-5,7,9,12,13,15-hexamethyl-10,16-dioxo-1,11-dioxaspiro(2.13)hexadecan-14-yl) acetate
- (2S,3R,4S,6R)-2-(((3R,5R,6S,7S,8R,11R,12S,13R,14S,15S)-6-acetoxy-12-(((2R,4S,5S,6S)-5-acetoxy-4-methoxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-5,7,8,11,13,15-hexamethyl-4,10-dioxo-1,9-dioxaspiro[2.13]hexadecan-14-yl)oxy)-4-(dimethylamino)-6-methyltetrahydro-2H-pyran-3-yl acetate
- (3R,5R,6R,7S,8R,11R,12S,13R,14S,15S)-12-((4-O-acetyl-2,6-dideoxy-3-O-methyl-alpha-L-arabino-hexopyranosyl)oxy)-14-((2-O-acetyl-3,4,6-trideoxy-3-(dimethylamino)-beta-D-xylo-hexopyranosyl)oxy)-5,7,8,11,13,15-hexamethyl-4,10-dioxo-1,9-dioxaspiro(2.13)hexadec-6-yl acetate
- (3R,5R,6S,7R,8R,11R,12S,13R,14S,15S)-12-[(4-O-acetyl-2,6-dideoxy-3-O-methyl-alpha-L-arabino-hexopyranosyl)oxy]-14-{[2-O-acetyl-3,4,6-trideoxy-3-(dimethylamino)-beta-D-xylo-hexopyranosyl]oxy}-5,7,8,11,13,15-hexamethyl-4,10-dioxo-1,9-dioxaspiro[2.13]hexadecan-6-yl acetate
- (3R,5R,6S,7S,8R,11R,12S,13R,14S,15S)-12-[(4-O-Acetyl-2,6-dideoxy-3-O-methyl-alpha-L-arabino-hexopyranosyl)oxy]-14-{[2-O-acetyl-3,4,6-trideoxy-3-(dimethylamino)-beta-D-xylo-hexopyranosyl]oxy}-5,7,8,11,13,15-hexamethyl-4,10-dioxo-1,9-dioxaspiro[2.13]hexadecan-6-yl acetate
- [(3R,5S,6S,7R,8S,9R,12R,13S,14S,15R)-6-[(2S,3R,4S,6R)-3-acetyloxy-4-(dimethylamino)-6-methyl-oxan-2-yl]oxy-8-[(2R,4S,5S,6S)-5-acetyloxy-4-methoxy-6-methyl-oxan-2-yl]oxy-5,7,9,12,13,15-hexamethyl-10,16-bis(oxidanylidene)-1,11-dioxaspiro[2.13]hexadecan-14-yl] ethanoate
- [(3R,5S,6S,7R,8S,9R,12R,13S,14S,15R)-6-[(2S,3R,4S,6R)-3-acetyloxy-4-(dimethylamino)-6-methyloxan-2-yl]oxy-8-[(2R,4S,5S,6S)-5-acetyloxy-4-methoxy-6-methyloxan-2-yl]oxy-5,7,9,12,13,15-hexamethyl-10,16-dioxo-2,11-dioxaspiro[2.13]hexadecan-14-yl] acetate
- 220-392-9